| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Epidémiologie Moléculaire des Entérovirus, Institut Pasteur, 25 rue du Dr Roux, 75015 Paris, France
Intertypic vaccine/vaccine recombinant polioviruses are frequently isolated from vaccine-associated paralytic poliomyelitis cases (VAPP). We identified a vaccine/nonvaccine poliovirus recombinant as the causative agent of a lethal VAPP. Partial RNA sequencing revealed a tripartite recombinant structure of the viral genome. This consisted of a central capsid core of vaccine origin flanked by two units of nonvaccine origin. The first nonvaccine genomic unit spanned the whole 5' noncoding region, and the second one almost the entire nonstructural protein-coding region and the 3' non-coding region. Amino acid and nucleotide sequence similarities in the 3' and 5' unidentified regions indicated that the viral donor(s) were poliovirus species, suggesting recombination between a vaccine-derived and a wild poliovirus. The nonvaccine donor(s) could not be identified among the investigated wild polioviruses co-circulating in the same geographical area. This is the first report of a natural recombination event occurring in the 5' genomic extremity of poliovirus. The neurovirulence for transgenic mice and the pathogenicity for humans of the recombinant suggested that the modular genomic organization of this virus might have conferred a selective advantage over its vaccine parent.
* Author for correspondence. Fax +33 1 45 68 87 80. e-mail mariuta@pasteur.fr
Received 7 March 1995;
accepted 25 May 1995.
This article has been cited by other articles:
|
|
 |
|
  C. Savolainen-Kopra, E. Samoilovich, H. Kahelin, A.-K. Hiekka, T. Hovi, and M. Roivainen Comparison of poliovirus recombinants: accumulation of point mutations provides further advantages J. Gen. Virol., August 1, 2009; 90(8): 1859 - 1868. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Macadam, G. Ferguson, D. M. Stone, J. Meredith, S. Knowlson, G. Auda, J. W. Almond, and P. D. Minor Rational design of genetically stable, live-attenuated poliovirus vaccines of all three serotypes: relevance to poliomyelitis eradication. J. Virol., September 1, 2006; 80(17): 8653 - 8663. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. C. Burns, J. Shaw, R. Campagnoli, J. Jorba, A. Vincent, J. Quay, and O. Kew Modulation of Poliovirus Replicative Fitness in HeLa Cells by Deoptimization of Synonymous Codon Usage in the Capsid Region. J. Virol., April 1, 2006; 80(7): 3259 - 3272. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. N. Lukashev, V. A. Lashkevich, O. E. Ivanova, G. A. Koroleva, A. E. Hinkkanen, and J. Ilonen Recombination in circulating Human enterovirus B: independent evolution of structural and non-structural genome regions J. Gen. Virol., December 1, 2005; 86(12): 3281 - 3290. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Karakasiliotis, E. Paximadi, and P. Markoulatos Evolution of a rare vaccine-derived multirecombinant poliovirus J. Gen. Virol., November 1, 2005; 86(11): 3137 - 3142. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Rakoto-Andrianarivelo, D. Rousset, R. Razafindratsimandresy, S. Chevaliez, S. Guillot, J. Balanant, and F. Delpeyroux High Frequency of Human Enterovirus Species C Circulation in Madagascar J. Clin. Microbiol., January 1, 2005; 43(1): 242 - 249. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Blomqvist, C. Savolainen, P. Laine, P. Hirttio, E. Lamminsalo, E. Penttila, S. Joks, M. Roivainen, and T. Hovi Characterization of a Highly Evolved Vaccine-Derived Poliovirus Type 3 Isolated from Sewage in Estonia J. Virol., May 1, 2004; 78(9): 4876 - 4883. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Oberste, S. Penaranda, and M. A. Pallansch RNA Recombination Plays a Major Role in Genomic Change during Circulation of Coxsackie B Viruses J. Virol., March 15, 2004; 78(6): 2948 - 2955. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Oberste, K. Maher, and M. A. Pallansch Evidence for Frequent Recombination within Species Human Enterovirus B Based on Complete Genomic Sequences of All Thirty-Seven Serotypes J. Virol., January 15, 2004; 78(2): 855 - 867. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-M. Liu, D.-P. Zheng, L.-B. Zhang, M. S. Oberste, O. M. Kew, and M. A. Pallansch Serial Recombination during Circulation of Type 1 Wild-Vaccine Recombinant Polioviruses in China J. Virol., October 15, 2003; 77(20): 10994 - 11005. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. N. Lukashev, V. A. Lashkevich, O. E. Ivanova, G. A. Koroleva, A. E. Hinkkanen, and J. Ilonen Recombination in Circulating Enteroviruses J. Virol., October 1, 2003; 77(19): 10423 - 10431. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-F. Yang, T. Naguib, S.-J. Yang, E. Nasr, J. Jorba, N. Ahmed, R. Campagnoli, H. van der Avoort, H. Shimizu, T. Yoneyama, et al. Circulation of Endemic Type 2 Vaccine-Derived Poliovirus in Egypt from 1983 to 1993 J. Virol., August 1, 2003; 77(15): 8366 - 8377. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Lindberg, P. Andersson, C. Savolainen, M. N. Mulders, and T. Hovi Evolution of the genome of Human enterovirus B: incongruence between phylogenies of the VP1 and 3CD regions indicates frequent recombination within the species J. Gen. Virol., May 1, 2003; 84(5): 1223 - 1235. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Blomqvist, A.-L. Bruu, M. Stenvik, and T. Hovi Characterization of a recombinant type 3/type 2 poliovirus isolated from a healthy vaccinee and containing a chimeric capsid protein VP1 J. Gen. Virol., March 1, 2003; 84(3): 573 - 580. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Martin, E. Samoilovich, G. Dunn, A. Lackenby, E. Feldman, A. Heath, E. Svirchevskaya, G. Cooper, M. Yermalovich, and P. D. Minor Isolation of an Intertypic Poliovirus Capsid Recombinant from a Child with Vaccine-Associated Paralytic Poliomyelitis J. Virol., October 2, 2002; 76(21): 10921 - 10928. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Oprisan, M. Combiescu, S. Guillot, V. Caro, A. Combiescu, F. Delpeyroux, and R. Crainic Natural genetic recombination between co-circulating heterotypic enteroviruses J. Gen. Virol., September 1, 2002; 83(9): 2193 - 2200. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. S. Cuervo, S. Guillot, N. Romanenkova, M. Combiescu, A. Aubert-Combiescu, M. Seghier, V. Caro, R. Crainic, and F. Delpeyroux Genomic Features of Intertypic Recombinant Sabin Poliovirus Strains Excreted by Primary Vaccinees J. Virol., July 1, 2001; 75(13): 5740 - 5751. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-M. Liu, D.-P. Zheng, L.-B. Zhang, M. S. Oberste, M. A. Pallansch, and O. M. Kew Molecular Evolution of a Type 1 Wild-Vaccine Poliovirus Recombinant during Widespread Circulation in China J. Virol., December 1, 2000; 74(23): 11153 - 11161. [Abstract] [Full Text]
|
|
|
|
|
|
S. Guillot, V. Caro, N. Cuervo, E. Korotkova, M. Combiescu, A. Persu, A. Aubert-Combiescu, F. Delpeyroux, and R. Crainic Natural Genetic Exchanges between Vaccine and Wild Poliovirus Strains in Humans J. Virol., September 15, 2000; 74(18): 8434 - 8443. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Divizia, L. Palombi, E. Buonomo, D. Donia, V. Ruscio, M. Equestre, L. Leno, A. Panà, and A. M. Degener Genomic Characterization of Human and Environmental Polioviruses Isolated in Albania Appl. Envir. Microbiol., August 1, 1999; 65(8): 3534 - 3539. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
